Relates to establishing an office of antibiotic-resistance control; establishes the antibiotics education fund; includes methicillin-resistant staphylococcus aureus (MRSA) and other antibiotic-resistant infections in the definition of airborne infectious disease.
This bill would create a new state office of antibiotic-resistance control within the Department of Health and establish an antibiotic-resistance control board to coordinate New York’s response to antibiotic resistance. The office would be responsible for integrating monitoring, education, research, and interagency coordination using a “One Health” approach that addresses human health, animal health, and the environment together. It would also set statewide goals for reducing healthcare-associated and community-acquired antibiotic-resistant infections, and for reducing the use of medically important antibiotics in food animal production.
The bill also creates a detailed regulatory framework for antibiotic use in agriculture. It would restrict when medically important antibiotics may be used in food-producing animals, require veterinarian oversight and reporting, prohibit use for growth promotion and routine disease prevention, and require annual reporting and public aggregation of antibiotic-use data. In addition, it would require hospitals and nursing homes to provide stewardship reports, direct the state to develop education and best-practice guidance, and create an annual public evaluation of statewide antibiotic-resistance programs. The bill further amends the labor law to include MRSA and other antibiotic-resistant infections in the definition of airborne infectious disease, which could affect workplace protections and employer obligations under that law.
The bill would amend the Public Health Law to add a new Title 9 on antibiotic-resistance control, create a new office and board, and authorize broad data collection, rulemaking recommendations, public reporting, and coordination across health, agriculture, education, and environmental agencies. It would also amend the State Finance Law to create the antibiotics education fund, financed by penalties collected under the new public health provisions, and earmarked for educational programs. Finally, it would amend the Labor Law’s airborne infectious disease definition to expressly include MRSA and other antibiotic-resistant infections as designated by the commissioner of health, potentially expanding the scope of workplace disease protections and related employer duties.
The bill’s stated purpose and structure reflect strong concern about antibiotic resistance and a policy preference for coordinated state action, stewardship, and reduced antibiotic use in both healthcare and agriculture. The bill text cites major public health organizations and frames the issue as an urgent statewide and global threat. No committee transcript or vote record was provided, so there is no documented legislative debate or recorded vote sentiment in the supplied materials.
The main likely points of contention are the bill’s agricultural restrictions and reporting requirements, which would impose new limits on medically important antibiotic use by livestock producers and veterinarians and require extensive data reporting. Farming interests may be concerned about operational burdens, veterinary access in rural areas, and limits on disease prevention practices, while public health advocates are likely to support tighter controls to reduce resistance. Another possible area of debate is the labor-law amendment adding MRSA and other antibiotic-resistant infections to airborne infectious disease protections, which could raise questions about scope, implementation, and employer compliance.